|
|
Article: On 7th April 2008, Novartis Reached an Agreement with Nestle Providing the Right to Acquire Majority (77 Per Cent) Ownership of Alcon.
- Article from:
- M2 Presswire
- Article date:
- June 3, 2009
CopyrightCOPYRIGHT 2009 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-3 June 2009-Research and Markets: On 7th April 2008, Novartis Reached an Agreement with Nestle Providing the Right to Acquire Majority (77 Per Cent) Ownership of Alcon(C)1994-2009 M2 COMMUNICATIONS
RDATE:02062009
Dublin - Research and Markets(http://www.researchandmarkets.com/research/9aae5e/alcon_performance) has announced the addition of the "Alcon: Performance, Products, Pipeline and Potential" company profile to their offering.
Alcon is a research and development-driven global company which develops, manufactures and markets pharmaceuticals, surgical equipment and devices, and consumer products to treat diseases and disorders of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Alcon scores legal victories in patent, trademark ...
Health & Medicine Week;
June 17, 2002 ;
700+ words
... ... in New Jersey has rejected claims that Alcon Laboratories, Inc.'s, Travatan, its ... competing drug called Xalatan, to enjoin Alcon's sale of Travatan, which has been on the market and prescribed since March 2001. Alcon Laboratories is a subsidiary of Alcon ...
|
|